Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase ib/iia trial

HIGHLIGHTS

• who: J. S. W. Borgers from the Department of Medical Oncology, Antoni Van Leeuwenhoek, The have published the article: Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial, in the Journal: (JOURNAL) of February/24,/2022
• what: In this trial the authors aim to investigate whether administration of FMT can reverse resistance to anti-PD-1 treatment in patients with advanced stage melanoma and whether the ICI-responsiveness of the feces donor is associated with its effectiveness. Interestingly, in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.